The report provides a detailed analysis essential for establishing a Lomefloxacin Hydrochloride production plant. It encompasses all critical aspects necessary for Lomefloxacin Hydrochloride production, including the cost of Lomefloxacin Hydrochloride production, Lomefloxacin Hydrochloride plant cost, Lomefloxacin Hydrochloride production costs, and the overall Lomefloxacin Hydrochloride production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Lomefloxacin Hydrochloride production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Lomefloxacin Hydrochloride is a broad-spectrum quinolone antibiotic that has a wide range of applications in the medical and pharmaceutical industries. It is mainly utilized as a medication for the treatment of bronchitis, urinary tract infections, respiratory, obstetric, and various other infections. It is also used as a preventative measure to reduce the risk of infections before or during surgical procedures. Additionally, it also finds its application as eye drops for the treatment of bacterial conjunctivitis and in the form of ear drops for the treatment of otitis externa and otitis media.
The market for Lomefloxacin Hydrochloride is primarily driven by its wide usage as a bactericidal agent for the treatment of various infections, including UTIs, bronchitis, etc., which remarkably boosts its demand in the medical and pharmaceutical industries. Additionally, its employment as a medication to treat skin, eye, ear, mouth, and throat infections further enhances its demand in the pharmaceutical industry. Furthermore, several factors influence industrial Lomefloxacin hydrochloride procurement, such as the availability and cost of production of its raw materials (pyridine, etc.), cost and pricing, supplier relationships, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Lomefloxacin Hydrochloride Production
According to the Lomefloxacin Hydrochloride production plant project report, the major raw material for Lomefloxacin Hydrochloride production includes Norfloxacin (1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3- carboxylic acid)- 2-Methylpiperazine- Pyridine-Methanol-Etrhanol.
Production Process of Lomefloxacin Hydrochloride
The extensive Lomefloxacin Hydrochloride production cost report consists of the following industrial production process:
- Production from 2-Methyl Piperazine: This method of production is initiated by heating 1.0g of 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3- carboxylic acid with 1.10g of 2-methylpiperazine and 10 ml of pyridine under reflux for 15 minutes. Further, the reaction mixture is subjected to evaporation, followed by the addition of methanol to the residue, its filtration, and recrystallization in the presence of ethanol to synthesize 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid or lomefloxacin as the product. Further, lomefloxacin solution is prepared and reacted with hydrochloric acid to obtain lomefloxacin hydrochloride as the desired product.
Lomefloxacin Hydrochloride is a form of the hydrochloride salt of lomefloxacin that appears as an odorless, white to, off-white crystalline powder. Its molecular formula is C17H20ClF2N3O3, and its molecular mass is 387.8 g/mol. Moreover, the melting point of the compound is 290-300°C. It is recommended to store this compound in a freezer under -20°C. It plays an important role as a fluoroquinolone antibacterial drug that acts against gram-negative and gram-positive organisms that cause various infections. Additionally, this drug is recognized as a DNA gyrase antagonist. It is mainly available in the form of oral tablets as well as topical eye and ear drops for the treatment of infection. This drug is also known as Maxaquin or Bareon. The chemical name of the compound is 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid.
